Tumor therapy with an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2

Details for Australian Patent Application No. 2007229008 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Friess, Thomas; Scheuer, Werner; Hasmann, Max

Agent Davies Collison Cave

Pub. Number AU-A-2007229008

PCT Pub. Number WO2007/107329

Priority 06021815.3 18.10.06 EP; 06111523.4 22.03.06 EP

Filing date 20 March 2007

Wipo publication date 27 September 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 September 2008 PCT application entered the National Phase

  PCT publication WO2007/107329 Priority application(s): WO2007/107329

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229009-Methods to maintain, improve and restore the cartilage phenotype of chondrocytes

2007229007-Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue